Posttraumatic epilepsy: the challenge of translating discoveries in the laboratory to pathways to a cure

Marc A Dichter1

  • 1Department of Neurology, University of Pennsylvania, Philadelphia 19104, USA. dichter@mail.med.upenn.edu

Epilepsia
|February 4, 2009
PubMed

Insights

Preventing epilepsy after brain injury is a priority. Parallel research in labs and clinical trials, alongside a dedicated consortium, is crucial for developing effective antiepileptogenic therapies.

Area of Science:

  • Neuroscience
  • Clinical Research
  • Translational Medicine

Background:

  • Preventing epilepsy after traumatic brain injury (TBI) and other lesions is a critical unmet medical need.
  • Translating laboratory findings into effective therapies faces significant challenges.
  • Current technological limitations, such as the lack of continuous electroencephalography (EEG) monitoring and validated biomarkers, hinder antiepileptogenesis trials.

Purpose of the Study:

  • To emphasize the urgent need for parallel research endeavors in laboratory experiments and human clinical studies for epilepsy prevention.
  • To advocate for the establishment of a dedicated consortium for antiepileptogenic studies in trauma centers.
  • To highlight the importance of developing cost-effective clinical protocols and continuous data mining for outcomes and surrogate markers.

Main Methods:

  • Proposes a parallel research approach combining laboratory experiments on epilepsy prevention mechanisms with clinical research in humans.
  • Suggests creating a consortium of trauma centers focused on antiepileptogenic studies.
  • Recommends experimenting with cost-effective clinical protocols and continuous data mining.

Main Results:

  • Acknowledges current technological limitations in monitoring and biomarker validation for antiepileptogenesis trials.
  • Emphasizes the necessity of advancing our understanding of epileptogenesis mechanisms.

Conclusions:

  • Urges immediate action to prioritize and fund long-term studies for epilepsy prevention.
  • Stresses the importance of parallel laboratory and clinical research to accelerate the development of therapies.
  • Anticipates that increased knowledge of epileptogenesis will enable the prevention of epilepsy following TBI and other insults.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...